XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
27.45
+1.47 (5.66%)
At close: Mar 9, 2026, 4:00 PM EDT
27.47
+0.02 (0.07%)
After-hours: Mar 9, 2026, 4:24 PM EDT
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$3,623,538
Profits / Employee
$758,154
Market Cap
326.34M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Cabaletta Bio | 151 |
| X4 Pharmaceuticals | 143 |
| Nautilus Biotechnology | 124 |
| Silence Therapeutics | 116 |
| C4 Therapeutics | 110 |
| Rezolute | 75 |
| Protara Therapeutics | 33 |
XOMA News
- 26 days ago - XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk - Seeking Alpha
- 4 weeks ago - XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - GlobeNewsWire
- 2 months ago - XOMA Royalty Announces CFO Transition - GlobeNewsWire
- 2 months ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 3 months ago - XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - GlobeNewsWire
- 3 months ago - Mural Oncology Announces Sanction of the Scheme by the High Court - GlobeNewsWire
- 3 months ago - XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - GlobeNewsWire
- 4 months ago - XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements - GlobeNewsWire